SEC Form 5 · accession 0001055726-16-000017
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morton Collins
Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2015 | G | 19,000 | $0.00 | D | 154,066 | D | |
| Common Stock | holding | — | — | — | 4,450 | I | By Spouse | |
| Common Stock | holding | — | — | — | 36,750 | I | By Collins Children's Trust | |
| Common Stock | holding | — | — | — | 2,675 | I | By Spouse IRA account | |
| Common Stock | holding | — | — | — | 36,750 | I | By Collin Grandchildren's Trust |
Table II — derivative securities
No Table II lines on this filing.